Icon PLC header image

Icon PLC

ICLR

Equity

ISIN IE0005711209 / Valor 1017575

NASDAQ (2026-10-06)
USD 161.69-3.94%

Icon PLC
UMushroom community rating:

star star star star star
2.00 1 votes No rating yet
NegativeNeutralPositive

About company

ICON plc is a leading global provider of outsourced drug and medical device development and commercialization services, catering to pharmaceutical, biotechnology, and medical device companies as well as government and public health organizations. The company specializes in managing the entire product lifecycle, including the planning, execution, and analysis of Phase I-IV clinical trials, which range from small single-site studies to large, multinational projects and advancements in cell and gene therapy. ICON also offers Functional Service Provision (FSP), delivering essential support services in areas such as finance, IT, human resources, sales, quality assurance, facilities, administration, legal, and procurement. With over 13,000 employees and more than 90 global partnerships, ICON integrates its Strategic Solutions teams within clients' operations to enhance efficiency and accelerate the market entry of new therapeutics and devices. Additionally, ICON is committed to developing talent through various early career programs, fostering a culture of continuous learning and professional growth.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-15.1%1Y
-32.6%3Y
-38.8%5Y

Performance

73.9%1Y
54.1%3Y
47.8%5Y

Volatility

Market cap

12475 M

Market cap (USD)

Daily traded volume (Shares)

984,008

Daily traded volume (Shares)

1 day high/low

211.185 / 207.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

2.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
1.00
Society:
starstarstarstarstar
1.00
Nature:
starstarstarstarstar
1.00
Aleenah Moghal
UK, 17 Feb 2026
star star star star star
Icon PLC faces significant uncertainty ue to an ongoing investigation into potential revenue overstatements for 2023–2025. this has led to significant price drops observed due to allegations that ICON plc may have issued materially misleading business information to the investing public.

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.30%USD 259.98
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.01%USD 7.31
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%GBP 119.58
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%GBP 10.12
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 23.27
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%USD 404.27
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.60%GBP 16.20
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%GBP 27.04
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.54
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 70.30